New use for cannabinoid

Roger Guy Pertwee (Inventor), Geoffrey Guy (Inventor)

Research output: Patent

Abstract

The present invention relates to the use of one or more cannabinoids in the manufacture of medicaments for use in the treatment of diseases and conditions benefiting from inverse agonism of the CB1 and / or the CB2 cannabinoid receptor. Preferably the cannabinoid is a cannabidiol (CBD) type compound or derivative thereof .
Original languageEnglish
Patent numberWO200713822
IPCA61K31/05; A61K31/352; A61P19/08;
Publication statusPublished - 6 Dec 2007

Fingerprint

Cannabinoids
Cannabidiol
Cannabinoid Receptor CB2

Cite this

Pertwee, R. G., & Guy, G. (2007). IPC No. A61K31/05; A61K31/352; A61P19/08; . New use for cannabinoid. (Patent No. WO200713822).

New use for cannabinoid. / Pertwee, Roger Guy (Inventor); Guy, Geoffrey (Inventor).

IPC No.: A61K31/05; A61K31/352; A61P19/08; . Patent No.: WO200713822.

Research output: Patent

Pertwee, RG & Guy, G 2007, New use for cannabinoid, Patent No. WO200713822, IPC No. A61K31/05; A61K31/352; A61P19/08; .
Pertwee RG, Guy G, inventors. New use for cannabinoid. A61K31/05; A61K31/352; A61P19/08; . 2007 Dec 6.
Pertwee, Roger Guy (Inventor) ; Guy, Geoffrey (Inventor). / New use for cannabinoid. IPC No.: A61K31/05; A61K31/352; A61P19/08; . Patent No.: WO200713822.
@misc{151bac2bfb584171972e40f264324f15,
title = "New use for cannabinoid",
abstract = "The present invention relates to the use of one or more cannabinoids in the manufacture of medicaments for use in the treatment of diseases and conditions benefiting from inverse agonism of the CB1 and / or the CB2 cannabinoid receptor. Preferably the cannabinoid is a cannabidiol (CBD) type compound or derivative thereof .",
author = "Pertwee, {Roger Guy} and Geoffrey Guy",
year = "2007",
month = "12",
day = "6",
language = "English",
type = "Patent",
note = "WO200713822; A61K31/05; A61K31/352; A61P19/08;",

}

TY - PAT

T1 - New use for cannabinoid

AU - Pertwee, Roger Guy

AU - Guy, Geoffrey

PY - 2007/12/6

Y1 - 2007/12/6

N2 - The present invention relates to the use of one or more cannabinoids in the manufacture of medicaments for use in the treatment of diseases and conditions benefiting from inverse agonism of the CB1 and / or the CB2 cannabinoid receptor. Preferably the cannabinoid is a cannabidiol (CBD) type compound or derivative thereof .

AB - The present invention relates to the use of one or more cannabinoids in the manufacture of medicaments for use in the treatment of diseases and conditions benefiting from inverse agonism of the CB1 and / or the CB2 cannabinoid receptor. Preferably the cannabinoid is a cannabidiol (CBD) type compound or derivative thereof .

M3 - Patent

M1 - WO200713822

ER -